Barclays
QNME

Barclays’s Quanome Technologies, Inc. Common Stock QNME Stock Holding History

Barclays’s Portfolio QNME Stock Details QNME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-157
Closed -$168 – 5610
2025
Q1 		$168 Buy
+157
New +$279 ﹤0.01% 5120

Other funds holding QNME

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays's QNME Position: Q2 2025 in Review

Barclays sold out of Quanome Technologies, Inc. Common Stock (QNME) in Q2 2025, closing a stake of 157 shares — an estimated $168 sold.

Barclays first reported a position in QNME in Q1 2025 and held it in 1 quarter. The position peaked at $168 in Q1 2025. 6 funds tracked by Wall St. Rank hold QNME as of Q2 2025.

  • Barclays reported no remaining Quanome Technologies, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 157 Quanome Technologies, Inc. Common Stock shares in Q2 2025, an estimated $168.
  • Barclays first reported a position in Quanome Technologies, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
  • Barclays's Quanome Technologies, Inc. Common Stock position peaked at $168 in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Quanome Technologies, Inc. Common Stock as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.